Ghost Tree Capital, LLC Solid Biosciences Inc. Transaction History

Ghost Tree Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.82 - $12.9 $282,000 - $1.29 Million	-100,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.19 - $32.37 $719,000 - $3.24 Million	100,000 New	100,000 $920,000
Q2 2018 Aug 14, 2018	SELL	$7.33 - $43.15 $2.82 Million - $16.6 Million	-385,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $2.77 Million - $12.8 Million	385,000 New	385,000 $2.89 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.